Board approves corrigendum to EGM notice for preferential issue

Fund Raising View source PDF Explain this filing

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+2.4%Reaction day

₹415.00

prior close

₹412.95

announcement price

In-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used+0.7%+1.7% vs market

Pharmaceuticals peers, median of 173sector+0.0%+2.4% vs sector

On the reaction day the stock moved 1.7 pts more than Nifty Microcap 250 and 2.4 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

—

10m

—

15m

—

30m

-0.7

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+2.4+0.7+1.7+0.0+2.4

Next day

-3.1-1.0-2.2-1.2-1.9

-6.5-3.6-2.9-2.8-3.7

-5.0-4.5-0.5-3.8-1.2

-1.2-6.8+5.6-5.1+3.9

+1.0-6.4+7.3-3.9+4.9

+3.6-4.7+8.3-0.9+4.6

15d

—————

UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 173Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Board on Oct 16, 2026 approved a corrigendum to the EGM notice for a preferential issue of 12,22,200 equity shares (proceeds about Rs 41.14 crore) and 5,00,400 warrants (proceeds about Rs 16.84 crore). Changes cover use of proceeds for working capital, subsidiary investments, and business expansion, plus updated UBO details and compliance certificates. Corrigendum will be sent to shareholders before the EGM.

Likely market impact

Shareholders will vote at EGM on the preferential issue. Issue will dilute existing equity and warrants may convert into more shares later.